Target Name: DZIP1
NCBI ID: G22873
Review Report on DZIP1 Target / Biomarker Content of Review Report on DZIP1 Target / Biomarker
DZIP1
Other Name(s): MVP3 | DAZ interacting zinc finger protein 1 | DZIP | zinc finger DAZ interacting protein 1 | DAZ-interacting zinc finger protein 1 | DAZ interacting protein 1 | DZIP1_HUMAN | DZIPt1 | zinc-finger protein DZIPt1 | Cilium assembly protein DZIP1 (isoform 2) | DAZ interacting protein testis1 | Zinc-finger protein DZIPt1 | DAZ-interacting protein 1/2 | zinc finger protein DZIP1 | Zinc finger DAZ interacting protein 1 | KIAA0996 | DZIP2 | DAZ interacting zinc finger protein 1, transcript variant 2 | SPGF47 | DZIP1 variant 2 | Zinc finger protein DZIP1

DZIP1: A Protein Potential Drug Target

DZIP1 (MVP3) is a protein that is expressed in various tissues throughout the body, including the brain, pancreas, and gastrointestinal tract. It is a member of the DZIP gene family, which encodes for small nuclear proteins that are involved in various cellular processes. One of the functions of DZIP1 is to regulate the activity of genes that encode for enzymes involved in the detoxification of xenobiotics, such as those that are found in our diet.

Recent studies have identified DZIP1 as a potential drug target for a variety of diseases, including cancer, neurodegenerative diseases, and gastrointestinal disorders. This is because DZIP1 has been shown to play a role in the regulation of cellular processes that are important for the development and progression of these diseases.

One of the ways that DZIP1 is thought to contribute to the development of cancer is by promoting the growth and survival of cancer cells. For example, studies have shown that DZIP1 can inhibit the activity of cell division proteins, which are essential for the growth and proliferation of cancer cells. This can lead to a reduction in the number of cancer cells that divide and grow, which could be an effective strategy for targeting cancer cells.

Another way that DZIP1 may contribute to the development of neurodegenerative diseases is by contributing to the build-up of toxic substances in the brain. For example, studies have shown that DZIP1 is involved in the detoxification of neurotoxins, which are substances that can cause damage to the brain. However, research has also shown that DZIP1 can accumulate toxic substances in the brain and contribute to the development of neurodegenerative diseases.

In addition to its role in neurodegenerative diseases, DZIP1 has also been shown to be involved in the regulation of the digestive system. For example, studies have shown that DZIP1 can regulate the activity of enzymes involved in the digestion of certain nutrients, such as lipids and carbohydrates. This could be important for maintaining the proper functioning of the digestive system and preventing digestive disorders.

Despite its potential as a drug target, DZIP1 is still a relatively little-known protein. There is currently limited research on the specific functions of DZIP1 in the body, and much of the research that has been done on this protein has focused on its potential as a drug target. However, as research continues to progress, it is likely that we will learn more about the role of DZIP1 in various cellular processes and how it contributes to the development and progression of disease.

In conclusion, DZIP1 is a protein that is expressed in various tissues throughout the body and is thought to play a role in the regulation of cellular processes that are important for the development and progression of a variety of diseases. Its potential as a drug target makes it an attractive target for researchers to investigate further and potentially develop as a new treatment for a variety of conditions. Further studies are needed to fully understand the role of DZIP1 in the body and its potential as a drug target.

Protein Name: DAZ Interacting Zinc Finger Protein 1

Functions: Molecular adapter that recruits protein complexes required for cilium assembly and function to the cilium basal body (PubMed:19852954, PubMed:23955340, PubMed:27979967, PubMed:32051257). At the exit of mitosis, localizes to the basal body and ciliary base of the forming primary cilium where it recruits and activates RAB8A to direct vesicle-mediated transport of proteins to the cilium (By similarity). Also recruits the BBSome, a complex involved in cilium biogenesis, by bridging it to PCM1 at the centriolar satellites of the cilium (PubMed:27979967). It is also required for the recruitment to the cilium basal body of the intraflagellar transport (IFT) machinery as well as the ciliary appendage proteins CEP164 and NINEIN (By similarity). Functions as a regulator of Hedgehog signaling both through its role in cilium assembly but also probably through its ability to retain GLI3 within the cytoplasm (By similarity). It is involved in spermatogenesis through its role in organization of the basal body and assembly of the sperm flagellum (PubMed:32051257). Also indirectly involved in heart development through its function in ciliogenesis (PubMed:31118289)

The "DZIP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DZIP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

DZIP1L | DZIP3 | E2F Transcription Factor | E2F-6 complex | E2F1 | E2F2 | E2F3 | E2F4 | E2F5 | E2F6 | E2F6P4 | E2F7 | E2F8 | E3 ubiquitin-protein ligase | E4F1 | EAF1 | EAF2 | EAPP | Early growth response | EARS2 | EBAG9 | EBF1 | EBF2 | EBF3 | EBF4 | EBI3 | EBLN1 | EBLN2 | EBLN3P | EBNA1BP2 | EBP | EBPL | ECD | ECE1 | ECE1-AS1 | ECE2 | ECEL1 | ECEL1P1 | ECEL1P2 | ECH1 | ECHDC1 | ECHDC2 | ECHDC3 | ECHS1 | ECI1 | ECI2 | ECI2-DT | ECM1 | ECM2 | ECPAS | ECRG4 | ECSCR | ECSIT | ECT2 | ECT2L | Ectonucleoside triphosphate diphosphohydrolase | EDA | EDA2R | EDAR | EDARADD | EDC3 | EDC4 | EDDM3A | EDDM3B | EDEM1 | EDEM2 | EDEM3 | EDF1 | EDIL3 | EDIL3-DT | EDN1 | EDN2 | EDN3 | EDNRA | EDNRB | EDNRB-AS1 | EDRF1 | EDRF1-AS1 | EDRF1-DT | EEA1 | EED | EEF1A1 | EEF1A1P11 | EEF1A1P14 | EEF1A1P19 | EEF1A1P22 | EEF1A1P25 | EEF1A1P28 | EEF1A1P3 | EEF1A1P30 | EEF1A1P38 | EEF1A1P44 | EEF1A1P47 | EEF1A1P5 | EEF1A1P6 | EEF1A1P9 | EEF1A2 | EEF1AKMT1 | EEF1AKMT2 | EEF1AKMT3